External factors
| External factors: |
MHY2233 |
| Category: |
Chemical compounds |
| Experiment: |
SA-β-gal activity assay//IP//qRT-PCR//western blot//Annexin V binding assay |
| Description: |
The results show that MHY2233 treatment significantly decreased the percentage of SA-β-gal-positive cells concentration-dependently. The results show that MHY2233 and resveratrol significantly reduced the percentage of apoptotic cells, whereas the percentage was increased by EX527 .MHY2233 treatment also decreased the mRNA levels of various SASPs, namely, IL-6, IL-8, IL-1α, and IL-1β. MHY2233 also increased the phosphorylation of eNOS on serine 1177 .treatment with MHY2233 decreased the mRNA levels of p16, p53, and p21. |
Warning: Undefined variable $target_genes in
/data/html/Aging-ReG/public/browse_detail_2.php on line
385
Regulatory relationship
| Regulatory pathway:
|
STAT1 |
| R-EF-Pathway:
|
Upregulation |
| Official symbol(s): |
Warning: Undefined variable $name_all in /data/html/Aging-ReG/public/browse_detail_2.php on line 525
STAT1
|
| Pathway experiment: |
Western blot//qRT-PCR |
| Pathway description: |
SIRT1 protein and mRNA levels were assessed in EPCs after concentration-dependent treatment with MHY2233. SIRT1 protein and mRNA levels both were upregulated with increasing concentrations of MHY2233 .The mRNA and protein levels of SIRT1 were increased by MHY2233 and resveratrol, but were decreased by EX527. |
Aging network
Annotation:
The green line represents Upregulation.
The purple line represents Downregulation.
The orange line represents Activation.
The yellow line represents Inhibition.
The gray line represents Unclear.